T-Cell Therapy Produced Prolonged Remission in Relapsed Pediatric ALL

December 9, 2014
Stephan Grupp, MD, PhD
Stephan Grupp, MD, PhD

In this video from the 2014 ASH Meeting, Dr. Grupp discusses data from a trial using CAR T-cell therapy in children and young adults with relapsed, treatment-resistant ALL.

Stephan Grupp, MD, PhD, of the Children’s Hospital of Philadelphia, discusses the long-term, follow-up data from a trial using CAR T-cell therapy in 39 children and young adults with relapsed, treatment-resistant acute lymphocytic leukemia.